Photo: Economic Times

Corbevax To Be Available As Booster Dose On COWIN App, Check Details

Corbevax, a recently authorised heterologous Covid-19 vaccine from the Hyderabad-based pharmaceutical firm Biological E, is slated to be accessible as a booster dosage via the COWIN App in both public and private vaccination centres beginning August 12. Corbevax costs Rs 250 for private COVID-19 immunisation centres, including Goods and Services Tax. The vaccination costs… read-more

Fri, 12 Aug 2022 - 01:20 PM / by Vidhi Jhunjhunwala

Tags: Corbevax, Covid Vaccine, Hyderabad, Booster Dose, heterologous COVID-19 vaccine

Courtesy: Zee news

India Surpasses 2 Billion Covid-19 Vaccine Dose Mark

Photo: The Quint

India Surpasses 2 Billion Covid-19 Vaccine Dose Mark After 18 Months Since Vaccinations Began In India

Dr. Mansukh Mandaviya, Union Health Minister, said on July 17 that India had attained the two-billion Covid-19 vaccine dosage threshold, 18 months after vaccinations began in the country on January 16, 2021. Prime Minister Narendra Modi also expressed his congratulations on the event, saying, "India creates history again!" Dr. Poonam Khetrapal Singh, Regional Director WHO South-East Asia, also congratulated the country on reaching the… read-more

Sun, 17 Jul 2022 - 05:11 PM / by Vidhi Jhunjhunwala

Tags: Covid-19, Covid Vaccine, India, 2 billion, Prime Minister Narendra Modi

Courtesy: Zee news

Covid Vaccination

Photo: ANI

Vaccines Provide Short-Term Protection Against COVID-19; Booster Injections Required: Study

Vaccination against SARS-CoV-2 virus provides only temporary protection, and reliable protection against reinfection necessitates regular booster shots with vaccines that have been modified to address changes in the virus that occur as part of its natural evolution over time, according to study. It is published in journal "Proceedings of the National Academy of Sciences." Study examines variations in covid immunity following vaccinations and… read-more

Sat, 16 Jul 2022 - 09:00 PM / by Vidhi Jhunjhunwala

Tags: Covid-19, Booster shot, Covid Vaccine, Study, protection

Courtesy: DNA INDIA


Photo: NDTV

Covaxin Safe For Children Aged 2-18, Finishes Clinical Trials: BBIL

Bharat Biotech International Limited (BBIL) announced that after phase II/III trials, Covaxin can safely be administered to children between ages two and 18. Reportedly, the phases II/III studies were conducted to evaluate the safety, reactogenicity and immunogenicity of the vaccine in healthy children and adolescents. "We have now achieved our goal of developing safe and efficacious Covid-19 vaccine for adults and children," said Dr Krishna… read-more

Fri, 17 Jun 2022 - 07:18 PM / by Shibu Immanuel S

Tags: Covaxin, BBIL, Covid-19, Covid Vaccine, children vaccine

Courtesy: ANI

(Representational Image)

Photo: Science Business

NTAGI To Review Covid Vaccine Data For Children In 5-12 Age Group

The NTAGI would review the Covid vaccine data for children in the age group of 5 to 12 years. This comes just days after the Drug Controller General of India (DCG) okayed Corbevax for children falling in the age bracket of 5 to 12 years, and Covaxin for children aged 6 to 12 years, for emergency use. The NTAGI recently also approved Covovax for children aged 12 to 17 years.

Mon, 02 May 2022 - 07:01 PM / by Varun Das

Tags: Covid Vaccine, Covid-19, Coronavirus, pandemic

Courtesy: ANI

Covishield and Covaxin

Photo: The Times Of India

Govt Unlikely To Reduce Gap Between Second Dose & Booster Dose: COVID-19

Amid speculations regarding the Government of India planning to reduce the gap between the second dose and the booster dose, government sources have confirmed that there are currently no such plans. SII CEO Adar Poonawalla had earlier urged the government to cut down the gap between doses. Some experts have, however, suggested that the longer the gap is between the doses, the stronger the immunity develops in the vaccine recipient.

Sun, 01 May 2022 - 10:15 AM / by Varun Das

Tags: Covid-19, Coronavirus, Vaccination, Covid Vaccine, Vaccination Drive

Courtesy: ANI

(Representational Image)

Photo: Science Business

Haryana Govt Rolls Out "Free" Boosters For 18-59 Age Group

The Haryana government has rolled out "free" booster doses for the 18-59 age group. The announcement came just days after the Delhi government made booster shots freely available for the age group. Around a whopping Rs 300 crores of taxpayers' money out of the state Covid-19 Relief Fund would be dedicated to this program. Experts are divided on the need for these "precautionary" doses.

Tue, 26 Apr 2022 - 03:30 PM / by Varun Das

Tags: Covid-19, Coronavirus, Covid Vaccine, COVISHIELD, Covaxin

Courtesy: Zee News

Children Vaccination Drive

Photo: The Hindu

COVID Vaccination Drive For Children Aged 12-14 Begins; Co-Morbidity Clause Removed

Children aged 12-14 years can now get their vaccine shots, starting from March 16. Corbevax vaccine manufactured by Hyderabad based Biological E, will be administered to children in the said age group. Also, everyone above 60 years of age are now eligible for a precautionary dose, starting from March 16. Initially, only those with pre-existing co-morbidities were eligible for the precautionary shot. 

Wed, 16 Mar 2022 - 10:03 AM / by Shibu Immanuel S

Tags: Covid Vaccine, children, precautionary shot, Corbevax, Hyderabad

Courtesy: ANI

COVID vaccine shots

Photo: The New Indian Express

Citizens Above 60 Years To Take Booster Dose From March 16

Citizens above 60-year-age are now eligible to take COVID-19 booster dose, to enhance immunity, from March 16.  Previously amid the third pandemic wave, the precautionary dose was allowed for frontline warriors and people with comorbidities. However, on March 14, Health Minister Mansukh Mandaviya announced the third vaccine shot for everyone, above 60-year. The decision came at a time, when the Union Government also approved COVID-19 vaccine… read-more

Mon, 14 Mar 2022 - 03:37 PM / by Rupsa Debnath

Tags: Covid-19, Coronavirus Vaccines, Covid Vaccine, Adults, vaccine dose

Courtesy: Hindustan Times

Dr Samira Bell

Photo: University of Dunde

2 COVID-19 Vaccine Doses Not Enough For Patients, Says Dr Samira Bell

Dr Samira Bell led a research, conducted by Scottish Renal Registry, establishing the study that two COVID-19 vaccine doses are not enough for patients with kidney transplant history and taking dialyses. Research on behalf of Public Health Scotland, found that such patients are less immune, and expose to health concerns and death-risk, even after taking two doses. The study also emphasised on need of third-fourth vaccine doses for such… read-more

Thu, 10 Mar 2022 - 08:59 PM / by Varsha Joshi

Tags: Covid-19, Covid Vaccine, Kidney Transplant, Dialyses, Scotland research